Dalian BIO-CHEM Company Limited (603360.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 22.53B |
| Enterprise Value | 22.42B |
| P/E Ratio | 47.52 |
| PEG Ratio | -1.6 |
| Price/Sales Ratio | 5.56 |
| Price/Book Ratio | 6.02 |
| Enterprise/Revenue | 5.84 |
| Enterprise/EBITDA | 22.59 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.11 |
| Operating Margin | 0.18 |
AD
Management Effectiveness
| Return On Assets | 0.04 |
| Return On Equity | 0.12 |
Income Statement
| Revenue | 1.72B |
| Revenue/Share | 2.26 |
| Gross Profit | 624.21M |
| EBITDA | 462.45M |
| Net Income | 209.77M |
| Diluted EPS | 0.3 |
Balance Sheet
| Total Cash | 1.02B |
| Total Cash/Share | 1.47 |
| Total Debt | 1.4B |
| Total Debt/Equity | 0.99 |
| Current Ratio | 2.81 |
| Book Value Per Share | 2.98 |
Price History
| 52-Week Change | -52.04 |
| 52-Week High | 38.98 |
| 52-Week Low | 11.18 |
| Moving Average 50 Days | 13.29 |
| Moving Average 200 Days | 23.13 |
Statistics
| Average Volume | 13.99M |
| Shares Outstanding | 706.22M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.15 |
| Last Split Factor | 7:5 |
| Last Split Date | May 29, 2025 |
AD
